GSK

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

Digital

The AI drug discovery race: Who’s leading the charge?

News

UK adds chickenpox to childhood vaccination schedule

The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.

News

Dynavax has GSK's shingles vaccine in its sights

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax wants to knock off its crown.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

News

FDA starts swift review of GSK antibiotic for gonorrhoea

An oral alternative to injectable treatment for uncomplicated gonorrhoea could be on the way in the US, as FDA starts review of GSK's gepotidacin.

As Trump visits UK, GSK pledges $30bn in US investment

The AI drug discovery race: Who’s leading the charge?

UK adds chickenpox to childhood vaccination schedule

Dynavax has GSK's shingles vaccine in its sights

Iterum brings first oral penem antibiotic to US market

FDA starts swift review of GSK antibiotic for gonorrhoea

Agios mulls early FDA filing for sickle cell therapy

Using AI-driven synthetic personas to take your insights fur...

GSK

Editor's Picks